Close Menu

NEW YORK (360Dx) – Empire Genomics has signed on Resnova as a distributor for its fluorescent in situ hybridization probes and molecular diagnostic services in Italy, the companies announced today.

In addition to custom, gene-specific, and chromosome control FISH probes, Empire offers a range of cancer genetic testing services for personalized medicine. Specific terms of the deal with Rome-based Resnova were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.